Prevention and Prophylaxis of SARS-CoV-2 Infection



Authors: NIH

The COVID-19 Treatment Guidelines Panel (the Panel) recommends that health care providers follow recommendations from the Advisory Committee on Immunization Practices when using SARS-CoV-2 vaccines (AI).The Panel recommends against the use of any drugs for SARS-CoV-2 pre-exposure prophylaxis (PrEP), except in a clinical trial (AIII).The Panel recommends against the use of hydroxychloroquine for SARS-CoV-2 post-exposure prophylaxis (PEP) (AI).The Panel recommends against the use of other drugs for SARS-CoV-2 PEP, except in a clinical trial (AIII).

For More Information: https://www.covid19treatmentguidelines.nih.gov/overview/prevention-of-sars-cov-2/

Leave a Reply

Your email address will not be published. Required fields are marked *